Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.

Hyaluronan-linked protein 1 (HAPLN1) which has been shown to be highly expressed in malignant pleural mesotheliomas (MPM), was detected in serum using an electrochemical surface-imprinting method. First, the detection method was optimized using Bovine serum albumin (BSA) as a model protein to mimic...

Full description

Bibliographic Details
Main Authors: Aabhas Mathur, Steven Blais, Chandra M V Goparaju, Thomas Neubert, Harvey Pass, Kalle Levon
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3596364?pdf=render
_version_ 1818961100948897792
author Aabhas Mathur
Steven Blais
Chandra M V Goparaju
Thomas Neubert
Harvey Pass
Kalle Levon
author_facet Aabhas Mathur
Steven Blais
Chandra M V Goparaju
Thomas Neubert
Harvey Pass
Kalle Levon
author_sort Aabhas Mathur
collection DOAJ
description Hyaluronan-linked protein 1 (HAPLN1) which has been shown to be highly expressed in malignant pleural mesotheliomas (MPM), was detected in serum using an electrochemical surface-imprinting method. First, the detection method was optimized using Bovine serum albumin (BSA) as a model protein to mimic the optimal conditions required to imprint the similar molecular weight protein HAPLN1. BSA was imprinted on the gold electrode with hydroxyl terminated alkane thiols, which formed a self-assembled monolayer (SAM) around BSA. The analyte (BSA) was then washed away and its imprint (empty cavity with shape-memory) was used for detection of BSA in a solution, using electrochemical open-circuit potential method, namely potentiometry. Factors considered to optimize the conditions include incubation time, protein concentration, limit of detection and size of electrode. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was used to confirm selectivity of imprints. With the obtained imprinting control parameters, HAPLN1 was imprinted in duplicate and the detection of spiked HAPLN1 was successfully conducted in serum.
first_indexed 2024-12-20T12:08:04Z
format Article
id doaj.art-af9f1ef8cb13405daa0470a22fc24be6
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-20T12:08:04Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-af9f1ef8cb13405daa0470a22fc24be62022-12-21T19:41:20ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5768110.1371/journal.pone.0057681Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.Aabhas MathurSteven BlaisChandra M V GoparajuThomas NeubertHarvey PassKalle LevonHyaluronan-linked protein 1 (HAPLN1) which has been shown to be highly expressed in malignant pleural mesotheliomas (MPM), was detected in serum using an electrochemical surface-imprinting method. First, the detection method was optimized using Bovine serum albumin (BSA) as a model protein to mimic the optimal conditions required to imprint the similar molecular weight protein HAPLN1. BSA was imprinted on the gold electrode with hydroxyl terminated alkane thiols, which formed a self-assembled monolayer (SAM) around BSA. The analyte (BSA) was then washed away and its imprint (empty cavity with shape-memory) was used for detection of BSA in a solution, using electrochemical open-circuit potential method, namely potentiometry. Factors considered to optimize the conditions include incubation time, protein concentration, limit of detection and size of electrode. Matrix assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) was used to confirm selectivity of imprints. With the obtained imprinting control parameters, HAPLN1 was imprinted in duplicate and the detection of spiked HAPLN1 was successfully conducted in serum.http://europepmc.org/articles/PMC3596364?pdf=render
spellingShingle Aabhas Mathur
Steven Blais
Chandra M V Goparaju
Thomas Neubert
Harvey Pass
Kalle Levon
Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
PLoS ONE
title Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
title_full Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
title_fullStr Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
title_full_unstemmed Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
title_short Development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting.
title_sort development of a biosensor for detection of pleural mesothelioma cancer biomarker using surface imprinting
url http://europepmc.org/articles/PMC3596364?pdf=render
work_keys_str_mv AT aabhasmathur developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting
AT stevenblais developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting
AT chandramvgoparaju developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting
AT thomasneubert developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting
AT harveypass developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting
AT kallelevon developmentofabiosensorfordetectionofpleuralmesotheliomacancerbiomarkerusingsurfaceimprinting